Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1951 1
1958 3
1959 1
1961 2
1962 1
1963 1
1965 3
1966 4
1967 2
1968 5
1969 5
1970 3
1971 6
1972 12
1973 8
1974 17
1975 12
1976 14
1977 10
1978 12
1979 5
1980 5
1981 2
1982 3
1983 1
1984 2
1990 1
1993 1
1998 1
1999 1
2007 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

146 results

Results by year

Filters applied: . Clear all
Page 1
Clinical pharmacokinetics of methotrexate.
Shen DD, Azarnoff DL. Shen DD, et al. Among authors: azarnoff dl. Clin Pharmacokinet. 1978 Jan-Feb;3(1):1-13. doi: 10.2165/00003088-197803010-00001. Clin Pharmacokinet. 1978. PMID: 346283 Review. No abstract available.
Clinical pharmacokinetics of disopyramide.
Karim A, Nissen C, Azarnoff DL. Karim A, et al. Among authors: azarnoff dl. J Pharmacokinet Biopharm. 1982 Oct;10(5):465-94. doi: 10.1007/BF01059032. J Pharmacokinet Biopharm. 1982. PMID: 6762414 Review. No abstract available.
Clinical principles of drug interactions in the adult patient.
Hurwitz A, Azarnoff DL. Hurwitz A, et al. Among authors: azarnoff dl. Ann N Y Acad Sci. 1976;281:98-105. doi: 10.1111/j.1749-6632.1976.tb27923.x. Ann N Y Acad Sci. 1976. PMID: 798532 Review. No abstract available.
Drug protein binding and the nephrotic syndrome.
Gugler R, Azarnoff DL. Gugler R, et al. Among authors: azarnoff dl. Clin Pharmacokinet. 1976;1(1):25-35. doi: 10.2165/00003088-197601010-00003. Clin Pharmacokinet. 1976. PMID: 797490 Review.
Drug development: risks and problems.
Azarnoff DL, Herting RL. Azarnoff DL, et al. Ann N Y Acad Sci. 1984;432:279-85. doi: 10.1111/j.1749-6632.1984.tb14527.x. Ann N Y Acad Sci. 1984. PMID: 6395765 Review. No abstract available.
Pharmacokinetics of methotrexate.
Azarnoff DL, Wan SH, Huffman DH. Azarnoff DL, et al. Clin Pharmacol Ther. 1974 Nov;16(5 Part 2):884-5. doi: 10.1002/cpt1974165part2884. Clin Pharmacol Ther. 1974. PMID: 4422029 No abstract available.
Pharmacokinetics of methotrexate.
Huffman DH, Wan SH, Azarnoff DL, Hogstraten B. Huffman DH, et al. Among authors: azarnoff dl. Clin Pharmacol Ther. 1973 Jul-Aug;14(4):572-9. doi: 10.1002/cpt1973144part1572. Clin Pharmacol Ther. 1973. PMID: 4723265 No abstract available.
Phenytoin: pharmacokinetics and bioavailability.
Gugler R, Manion CV, Azarnoff DL. Gugler R, et al. Among authors: azarnoff dl. Clin Pharmacol Ther. 1976 Feb;19(2):135-42. doi: 10.1002/cpt1976192135. Clin Pharmacol Ther. 1976. PMID: 1261151
146 results